scholarly article | Q13442814 |
P2093 | author name string | Lin Zhou | |
Xiao-Bo Yu | |||
Hai-Yang Xie | |||
Shu-Sen Zheng | |||
Chun-Hui Nie | |||
Jun-Hui Sun | |||
Yue-Lin Zhang | |||
Su-Ping Qian | |||
P2860 | cites work | Effects of MRI Contrast Agents on the Stem Cell Phenotype | Q56777725 |
Bioenergetic and Functional Consequences of Bone Marrow-Derived Multipotent Progenitor Cell Transplantation in Hearts With Postinfarction Left Ventricular Remodeling | Q56777840 | ||
Magnetic resonance mapping of transplanted endothelial progenitor cells for therapeutic neovascularization in ischemic heart disease | Q57188019 | ||
Molecular imaging: exploring the next frontier | Q78227386 | ||
Bone marrow mesenchymal stem cells ameliorate rat acute renal failure by differentiation into renal tubular epithelial-like cells | Q81774923 | ||
Circulating endothelial progenitor cells and cardiovascular outcomes | Q28271167 | ||
Isolation of putative progenitor endothelial cells for angiogenesis | Q28302884 | ||
Mobilized bone marrow cells repair the infarcted heart, improving function and survival | Q31002195 | ||
Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms | Q31147648 | ||
Vascular endothelial growth inhibitor (VEGI; TNFSF15) inhibits bone marrow-derived endothelial progenitor cell incorporation into Lewis lung carcinoma tumors | Q34587733 | ||
Endothelial progenitor cell biology in disease and tissue regeneration | Q35069503 | ||
Endothelial progenitor cells: mobilization, differentiation, and homing | Q35114634 | ||
Endothelial progenitor cells for vasculogenesis | Q36011396 | ||
Progenitor cells in vascular disease. | Q36275672 | ||
Clinical and therapeutical implications of EPC biology in atherosclerosis | Q36517055 | ||
The role of endothelial progenitor cells in ischemic cerebral and heart diseases | Q36822315 | ||
Heart failure therapy mediated by the trophic activities of bone marrow mesenchymal stem cells: a noninvasive therapeutic regimen | Q37276182 | ||
Prospects for stem cell transplantation in the treatment of hepatic disease | Q37768108 | ||
Magnetic labeling, imaging and manipulation of endothelial progenitor cells using iron oxide nanoparticles | Q37855910 | ||
Putting the neo into neoangiogenesis | Q39737509 | ||
Efficient labeling of mesenchymal stem cells using cell permeable magnetic nanoparticles | Q39902714 | ||
Mesenchymal stem cell targeting of microscopic tumors and tumor stroma development monitored by noninvasive in vivo positron emission tomography imaging | Q40353003 | ||
Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair | Q40417766 | ||
Tracking transplanted stem cell migration using bifunctional, contrast agent-enhanced, magnetic resonance imaging | Q40697945 | ||
Superparamagnetic iron oxide nanoparticles may affect endothelial progenitor cell migration ability and adhesion capacity | Q43144995 | ||
Targeting of hematopoietic progenitor cells with MR contrast agents. | Q44526114 | ||
Circulating endothelial progenitor cells and age-related white matter changes. | Q45921371 | ||
Human mesenchymal stem cells xenografted directly to rat liver are differentiated into human hepatocytes without fusion. | Q46427722 | ||
Effect of human stem cells labeled with ferumoxides-poly-L-lysine on hematologic and biochemical measurements in rats | Q46461083 | ||
Magnetic resonance tracking of human CD34+ progenitor cells separated by means of immunomagnetic selection and transplanted into injured rat brain | Q48874771 | ||
In vivo tracking of bone marrow stromal cells transplanted into mice cerebral infarct by fluorescence optical imaging | Q48962260 | ||
Differentiation and proliferation of endothelial progenitor cells from canine peripheral blood mononuclear cells. | Q51452698 | ||
P433 | issue | 2 | |
P921 | main subject | nanoparticle | Q61231 |
endothelium | Q111140 | ||
P304 | page(s) | 282-286 | |
P577 | publication date | 2012-05-10 | |
P1433 | published in | Molecular Medicine Reports | Q26842180 |
P1476 | title | In vitro labeling of endothelial progenitor cells isolated from peripheral blood with superparamagnetic iron oxide nanoparticles | |
P478 | volume | 6 |
Q41540394 | Autonomous magnetic labelling of functional mesenchymal stem cells for improved traceability and spatial control in cell therapy applications. |
Q36408240 | Cell Labeling and Targeting with Superparamagnetic Iron Oxide Nanoparticles |
Q42505070 | Determine exogenous human DDAH2 gene function in rabbit bone marrow-derived endothelial progenitor cells in vitro. |
Q45875518 | Effects of lentivirus-mediated endostatin on endothelial progenitor cells |
Q99612023 | Endothelial progenitor cells in the peripheral blood of patients with moyamoya disease labeled with superparamagnetic iron oxide in vitro for MRI detection |
Q54096511 | Generation of an anti-angiogenic endothelial progenitor cell line via endostatin gene transfer. |
Q39159310 | Tumour cell labelling by magnetic nanoparticles with determination of intracellular iron content and spatial distribution of the intracellular iron. |
Q35036530 | Viability, differentiation capacity, and detectability of super-paramagnetic iron oxide-labeled muscle precursor cells for magnetic-resonance imaging |
Search more.